Steris Plc (STE) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2027, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the STE SEC filings page.
Steris Plc (STE) reported $6.0B in revenue over the twelve months to Jun 30, 2026, up 8.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Operating leverage is converting steady revenue growth into wider margins, stronger cash generation, and a progressively less debt-dependent balance sheet.
From FY2024 to FY2026, operating cash flow rose from$973M to$1.34B , indicating that profit growth was accompanied by cash rather than remaining mainly accrual-based. Capital expenditures were$369M in FY2026, close to$360M in FY2024, so free-cash-flow expansion reflects stronger internal cash production more than reduced reinvestment.
In FY2026, revenue grew
Debt-to-equity fell from 0.5x in FY2024 to 0.3x in FY2026, while total liabilities declined, showing a less leveraged funding structure. Interest expense fell to
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Steris Plc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Steris Plc has an operating margin of 18.6%, meaning the company retains $19 of operating profit per $100 of revenue. This strong profitability earns a score of 82/100, reflecting efficient cost management and pricing power. This is up from 15.9% the prior year.
Steris Plc's revenue grew 8.7% year-over-year to $5.9B, a solid pace of expansion. This earns a growth score of 58/100.
Steris Plc has a moderate D/E ratio of 0.25. This balance of debt and equity financing earns a leverage score of 51/100.
Steris Plc's current ratio of 2.09 indicates adequate short-term liquidity, earning a score of 61/100. The company can meet its near-term obligations, though with limited headroom.
Steris Plc converts 16.4% of revenue into free cash flow ($972.4M). This strong cash generation earns a score of 78/100.
Steris Plc earns a strong 10.9% return on equity (ROE), meaning it generates $11 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 70/100. This is up from 9.3% the prior year.
Steris Plc scores 4.98, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($21.0B) relative to total liabilities ($3.5B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Steris Plc passes 9 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Steris Plc generates $1.71 in operating cash flow ($1.3B OCF vs $782.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Steris Plc earns $18.15 in operating income for every $1 of interest expense ($1.1B vs $60.7M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Steris Plc generated $1.5B in revenue in Q1 2027. This represents an increase of 7.3% from the same quarter a year earlier. Against the prior quarter it is down 6.0%.
Steris Plc's EBITDA was $409.6M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 12.1% from the same quarter a year earlier. Against the prior quarter it is down 7.0%.
Steris Plc reported $200.1M in net income in Q1 2027. This represents an increase of 12.8% from the same quarter a year earlier. Against the prior quarter it is down 9.1%.
Steris Plc earned $2.04 per diluted share (EPS) in Q1 2027. This represents an increase of 14.0% from the same quarter a year earlier. Against the prior quarter it is down 8.9%.
Cash & Balance Sheet
Steris Plc generated $279.6M in free cash flow in Q1 2027, representing cash available after capex. This represents a decrease of 14.3% from the same quarter a year earlier. Against the prior quarter it is up 14.0%.
Steris Plc held $482.3M in cash against $1.7B in long-term debt as of Q1 2027.
Steris Plc paid $0.63 per share in dividends in Q1 2027. This represents an increase of 10.5% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Steris Plc's gross margin was 45.8% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.
Steris Plc's operating margin was 19.1% in Q1 2027, reflecting core business profitability. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.
Steris Plc's net profit margin was 13.4% in Q1 2027, showing the share of revenue converted to profit. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.
Steris Plc's ROE was 2.8% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.3 percentage points.
Capital Allocation
Steris Plc invested $28.6M in research and development in Q1 2027. This represents an increase of 8.3% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.
Steris Plc spent $115.5M on share buybacks in Q1 2027, returning capital to shareholders by reducing shares outstanding. This represents an increase of 989.6% from the same quarter a year earlier. Against the prior quarter it is up 55.5%.
Steris Plc invested $87.5M in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 6.5% from the same quarter a year earlier. Against the prior quarter it is down 3.0%.
STE Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B+7.3% | $1.6B+7.3% | $1.5B+9.2% | $1.5B+9.9% | $1.4B+8.7% | $1.5B+4.3% | $1.4B+5.6% | $1.3B+7.3% |
| Cost of Revenue | $808.6M+6.0% | $891.2M+6.2% | $840.7M+10.6% | $814.4M+8.6% | $763.1M+7.9% | $839.4M+0.3% | $760.2M+3.1% | $750.1M+8.4% |
| Gross Profit | $684.2M+8.9% | $697.1M+8.7% | $655.5M+7.4% | $645.9M+11.6% | $628.0M+9.7% | $641.3M+10.0% | $610.3M+9.0% | $578.8M+6.0% |
| R&D Expenses | $28.6M+8.3% | $28.8M+4.3% | $29.5M+7.7% | $28.2M+4.4% | $26.4M+3.1% | $27.6M | $27.4M+8.5% | $27.0M+2.8% |
| SG&A Expenses | $369.7M+4.5% | $351.9M+5.4% | $352.3M+5.0% | $349.7M+6.2% | $353.8M+5.4% | $333.9M | $335.5M+8.8% | $329.3M+0.3% |
| Operating Income | $285.8M+16.2% | $316.8M+46.6% | $273.2M+11.4% | $265.8M+21.0% | $246.0M+32.6% | $216.1M | $245.3M+8.3% | $219.7M+14.7% |
| EBITDA | $409.6M+12.1% | $440.2M+30.1% | $395.2M+6.5% | $387.5M+15.7% | $365.4M+22.5% | $338.4M | $371.2M+1.1% | $335.0M-2.6% |
| Interest Expense | $15.8M-0.6% | $15.0M-12.4% | $14.9M-22.0% | $14.9M-24.4% | $15.9M-47.7% | $17.1M | $19.1M-51.0% | $19.7M-46.7% |
| Income Tax | $72.5M+34.5% | $84.2M+66.7% | $63.5M+14.6% | $60.6M+39.3% | $53.9M+52.7% | $50.5M+35.5% | $55.4M+35.1% | $43.5M+24.1% |
| Net Income | $200.1M+12.8% | $220.1M+51.1% | $192.9M+11.2% | $191.9M+27.9% | $177.4M+22.0% | $145.7M+10681.0% | $173.5M+23.3% | $150.0M+30.1% |
| EPS (Basic) | $2.05+13.9% | $2.25+51.0% | $1.96+11.4% | $1.95+28.3% | $1.80+22.4% | $1.49+15000.0% | $1.76+23.9% | $1.52+29.9% |
| EPS (Diluted) | $2.04+14.0% | $2.24+52.4% | $1.96+12.0% | $1.94+28.5% | $1.79+22.6% | $1.47+14800.0% | $1.75+23.2% | $1.51+30.2% |
| Diluted Shares (Avg) | 98M-0.9% | N/A | 99M-0.3% | 99M-0.4% | 99M-0.6% | N/A | 99M-0.5% | 99M-0.2% |
STE Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.7B+3.2% | $10.7B+5.8% | $10.6B+5.8% | $10.4B+1.6% | $10.4B+2.9% | $10.1B-8.3% | $10.0B-12.5% | $10.2B-9.2% |
| Current Assets | $2.4B+18.9% | $2.4B+19.7% | $2.3B+20.5% | $2.1B+8.7% | $2.1B+6.0% | $2.0B-30.3% | $1.9B-14.5% | $1.9B-10.9% |
| Cash & Equivalents | $482.3M+72.4% | $439.6M+156.0% | $423.7M+173.0% | $319.2M+85.4% | $279.7M+41.0% | $171.7M-17.1% | $155.2M-20.7% | $172.2M-19.4% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $712.1M+11.1% | $631.8M+8.7% | $673.5M+3.7% | $658.5M-4.4% | $641.2M-8.2% | $581.3M-13.8% | $649.6M-24.1% | $688.9M-16.1% |
| Accounts Receivable | $1.0B+7.0% | $1.1B+4.7% | $990.6M+8.2% | $947.3M+2.6% | $947.1M+6.1% | $1.0B+3.5% | $915.2M-5.1% | $923.3M-1.8% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $4.2B-0.8% | $4.2B+2.4% | $4.2B+4.6% | $4.2B+1.5% | $4.2B+4.1% | $4.1B+0.6% | $4.0B-1.6% | $4.2B+2.8% |
| Total Liabilities | $3.5B+2.3% | $3.5B+0.3% | $3.4B-4.4% | $3.4B-6.7% | $3.4B-8.1% | $3.5B-25.6% | $3.6B-28.5% | $3.6B-28.7% |
| Current Liabilities | $1.3B+38.5% | $1.1B+12.0% | $922.3M+3.5% | $888.9M+10.4% | $926.6M+11.1% | $1.0B+9.8% | $891.1M-2.5% | $805.5M-7.7% |
| Non-Current Liabilities | $2.2B-11.0% | $2.4B-4.5% | $2.5B-7.0% | $2.5B-11.6% | $2.5B-13.6% | $2.5B-34.3% | $2.7B-34.3% | $2.8B-33.0% |
| Long-Term Debt | $1.7B-13.3% | $1.8B-5.5% | $1.9B-6.9% | $1.9B-12.0% | $1.9B-14.9% | $1.9B-38.5% | $2.0B-36.9% | $2.2B-35.9% |
| Total Equity | $7.2B+3.6% | $7.2B+8.8% | $7.2B+11.5% | $7.0B+6.3% | $7.0B+9.5% | $6.6B+4.8% | $6.4B0.0% | $6.6B+6.7% |
| Retained Earnings | $3.2B+21.5% | $3.0B+21.8% | $2.9B+19.8% | $2.7B+20.2% | $2.6B+19.2% | $2.5B+18.6% | $2.4B+11.8% | $2.3B+10.9% |
STE Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $367.1M-12.6% | $335.4M+28.6% | $298.2M-10.4% | $287.8M+14.8% | $420.0M+38.3% | $260.8M+2.3% | $332.8M+14.3% | $250.8M+71.7% |
| Depreciation & Amortization | $123.8M+3.7% | $123.4M+0.9% | $122.0M-3.1% | $121.7M+5.6% | $119.4M+5.9% | $122.3M-9.0% | $125.9M-10.5% | $115.3M-24.3% |
| Stock-Based Compensation | $12.8M+7.6% | N/A | N/A | N/A | $11.9M+3.5% | N/A | N/A | N/A |
| Capital Expenditures | $87.5M-6.5% | $90.2M+27.2% | $98.7M+10.7% | $86.5M-15.1% | $93.6M-13.4% | $70.9M-22.5% | $89.2M-25.0% | $101.9M+22.3% |
| Free Cash Flow | $279.6M-14.3% | $245.2M+29.1% | $199.5M-18.1% | $201.3M+35.2% | $326.4M+66.9% | $189.9M+16.2% | $243.6M+41.4% | $148.9M+137.1% |
| Investing Cash Flow | -$108.5M0.0% | -$217.2M-211.2% | -$98.5M+20.5% | -$88.3M+16.1% | -$108.5M-115.8% | -$69.8M+27.0% | -$123.9M-4.2% | -$105.3M+82.6% |
| Financing Cash Flow | -$213.5M-0.2% | -$97.9M+45.0% | -$98.0M+54.3% | -$159.2M+12.0% | -$213.1M+78.7% | -$178.1M-23.9% | -$214.4M-8.3% | -$181.0M-138.5% |
| Dividends Paid | $61.4M+9.3% | $61.8M+10.4% | $61.9M+10.1% | $61.9M+9.9% | $56.2M+9.3% | $56.0M+8.9% | $56.2M+9.4% | $56.3M+9.6% |
| Share Buybacks | $115.5M+989.6% | $74.3M+37050.0% | $50.1M-50.1% | $100.5M+116.5% | $10.6M-83.5% | $200K-44.4% | $100.5M+4410.8% | $46.4M+9393.3% |
STE Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.8%+0.7pp | 43.9%+0.6pp | 43.8%-0.7pp | 44.2%+0.7pp | 45.1%+0.4pp | 43.3%+2.2pp | 44.5%+1.4pp | 43.5%-0.6pp |
| Operating Margin | 19.1%+1.5pp | 20.0%+5.4pp | 18.3%+0.4pp | 18.2%+1.7pp | 17.7%+3.2pp | 14.6% | 17.9%+0.5pp | 16.5%+1.1pp |
| Net Margin | 13.4%+0.7pp | 13.9%+4.0pp | 12.9%+0.2pp | 13.1%+1.8pp | 12.8%+1.4pp | 9.8%+9.9pp | 12.7%+1.8pp | 11.3%+2.0pp |
| Return on Equity | 2.8%+0.2pp | 3.1%+0.8pp | 2.7%0.0pp | 2.7%+0.5pp | 2.5%+0.3pp | 2.2%+2.2pp | 2.7%+0.5pp | 2.3%+0.4pp |
| Return on Assets | 1.9%+0.2pp | 2.1%+0.6pp | 1.8%+0.1pp | 1.8%+0.4pp | 1.7%+0.3pp | 1.4%+1.4pp | 1.7%+0.5pp | 1.5%+0.4pp |
| Current Ratio | 1.91-0.3x | 2.09+0.1x | 2.48+0.3x | 2.370.0x | 2.22-0.1x | 1.96-1.1x | 2.13-0.3x | 2.41-0.1x |
| Debt-to-Equity | 0.230.0x | 0.250.0x | 0.27-0.1x | 0.27-0.1x | 0.27-0.1x | 0.29-0.2x | 0.32-0.2x | 0.33-0.2x |
| Asset Turnover | 0.140.0x | 0.150.0x | 0.140.0x | 0.140.0x | 0.130.0x | 0.150.0x | 0.140.0x | 0.130.0x |
| FCF Margin | 18.7%-4.7pp | 15.4%+2.6pp | 13.3%-4.4pp | 13.8%+2.6pp | 23.5%+8.2pp | 12.8%+1.3pp | 17.8%+4.5pp | 11.2%+6.1pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Steris Plc STE | FY2026 | $5.9B | $782.3M | 13.2% | $21.0B | 67/100 |
| Insulet Corp PODD | FY2025 | $2.7B | $247.1M | 9.1% | $9.6B | 75/100 |
| Dexcom Inc DXCM | FY2025 | $4.7B | $836.3M | 17.9% | $31.7B | 69/100 |
| Zimmer Biomet ZBH | FY2025 | $8.2B | $705.1M | 8.6% | $18.0B | 59/100 |
| Smith & Nephew SNN | FY2025 | $6.2B | $625.0M | 10.1% | $11.6B | 35/100 |
Where Steris Plc Ranks
Frequently Asked Questions
What is Steris Plc's annual revenue?
Steris Plc (STE) reported $5.9B in total revenue for fiscal year 2026. This represents a 8.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Steris Plc's revenue growing?
Steris Plc (STE) revenue grew by 8.7% year-over-year, from $5.5B to $5.9B in fiscal year 2026.
Is Steris Plc profitable?
Yes, Steris Plc (STE) reported a net income of $782.3M in fiscal year 2026, with a net profit margin of 13.2%.
What is Steris Plc's EBITDA?
Steris Plc (STE) had EBITDA of $1.6B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Steris Plc have?
As of fiscal year 2026, Steris Plc (STE) had $439.6M in cash and equivalents against $1.8B in long-term debt.
What is Steris Plc's gross margin?
Steris Plc (STE) had a gross margin of 44.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Steris Plc's operating margin?
Steris Plc (STE) had an operating margin of 18.6% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Steris Plc's net profit margin?
Steris Plc (STE) had a net profit margin of 13.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Does Steris Plc pay dividends?
Yes, Steris Plc (STE) paid $2.46 per share in dividends during fiscal year 2026.
What is Steris Plc's return on equity (ROE)?
Steris Plc (STE) has a return on equity of 10.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Steris Plc's free cash flow?
Steris Plc (STE) generated $972.4M in free cash flow during fiscal year 2026. This represents a 25.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Steris Plc's operating cash flow?
Steris Plc (STE) generated $1.3B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Steris Plc's total assets?
Steris Plc (STE) had $10.7B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Steris Plc's capital expenditures?
Steris Plc (STE) invested $369.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Steris Plc spend on research and development?
Steris Plc (STE) invested $112.9M in research and development during fiscal year 2026.
What is Steris Plc's current ratio?
Steris Plc (STE) had a current ratio of 2.09 as of fiscal year 2026, which is generally considered healthy.
What is Steris Plc's debt-to-equity ratio?
Steris Plc (STE) had a debt-to-equity ratio of 0.25 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Steris Plc's return on assets (ROA)?
Steris Plc (STE) had a return on assets of 7.3% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Steris Plc's P/E ratio?
Steris Plc (STE) trades at 26.1x earnings, its market capitalization divided by net income of $805.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $21.0B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Steris Plc's price-to-sales ratio?
Steris Plc (STE) trades at 3.5x sales, its market capitalization divided by revenue of $6.0B revenue, trailing 12 months to June 30, 2026. The market capitalization is $21.0B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Steris Plc's Altman Z-Score?
Steris Plc (STE) has an Altman Z-Score of 4.98, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Steris Plc's Piotroski F-Score?
Steris Plc (STE) has a Piotroski F-Score of 9 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Steris Plc's earnings high quality?
Steris Plc (STE) has an earnings quality ratio of 1.71x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Steris Plc cover its interest payments?
Steris Plc (STE) has an interest coverage ratio of 18.15x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Steris Plc?
Steris Plc (STE) scores 67 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.